Understanding Migraine Prevention vs. Relief Medicine: Key Differences

Migraine management involves two distinct therapeutic approaches: prevention and acute relief. Understanding the difference between these treatment strategies is essential for effective migraine care and can help patients work with their healthcare providers to develop comprehensive treatment plans.

Prevention medications, also called prophylactic treatments, are taken regularly to reduce the frequency, severity, and duration of migraine attacks before they occur. These medications include CGRP inhibitors like Qulipta for oral prevention, injectable options such as Emgality, Aimovig, Ajovy, and Vyepti, as well as established treatments like Botox for chronic migraine. Prevention therapy is typically recommended for patients experiencing frequent migraines or those whose attacks significantly impact daily functioning.

Acute relief medications, in contrast, are taken during a migraine attack to stop or reduce symptoms once they begin. These treatments include CGRP receptor antagonists like Ubrelvy, Nurtec ODT, Reyvow, and Zavzpret, which work to interrupt the migraine process. The goal of acute treatment is to provide rapid symptom relief and restore normal function as quickly as possible.

Many patients benefit from a combination approach, using both prevention and acute relief medications as part of their migraine management strategy. Prevention medications work to reduce overall migraine burden, while acute treatments provide relief when breakthrough attacks occur. Healthcare providers consider factors such as migraine frequency, severity, patient lifestyle, and treatment response when determining the most appropriate therapeutic approach for each individual.